ERBB2 and breast cancer: As higher infiltration of immune cells and expression of immune activation markers are seen in HER2+ BC primary lesions compared to metastatic tissues [38], we attempted to determine the relationship between exosomes and prognosis or microenvironment in patients with HER2+ BC.